Cargando…
Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice
We previously showed that intraosseous (IO) delivery of factor VIII (FVIII, gene F8) lentiviral vector (LV) driven by the megakaryocyte-specific promoter Gp1bα (G-F8-LV) partially corrected the bleeding phenotype in hemophilia A (HemA) mice for up to 5 months. In this study, we further characterized...
Autores principales: | Joo, Julia H., Wang, Xuefeng, Singh, Swati, Chen, Chun-Yu, Li, Chong, Adair, Jennifer E., Kiem, Hans-Peter, Rawlings, David J., Miao, Carol H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577625/ https://www.ncbi.nlm.nih.gov/pubmed/35849710 http://dx.doi.org/10.1182/bloodadvances.2022008079 |
Ejemplares similares
-
Hemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectors
por: Miao, Carol H.
Publicado: (2016) -
Delivery of Factor VIII Gene into Skeletal Muscle Cells Using Lentiviral Vector
por: Jeon, Hyun Jeong, et al.
Publicado: (2010) -
Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector
por: Singh, Swati, et al.
Publicado: (2016) -
Abrogated cryptic activation of lentiviral transfer vectors
por: Luche, Ralf M., et al.
Publicado: (2012) -
Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis In Vivo
por: Adigbli, George, et al.
Publicado: (2021)